Coronavirus expert commentaries

Short commentaries on scientific and societal responses to the COVID-19 pandemic, from researchers around the world and across disciplines.

Add your expertise
Submit your suggestion for an interview video or new research direction. »Send your idea

COVID-19 science videos

Coronavirus #COVID19 #SARSCoV2 #surgeon #surgery Performing surgery during a global pandemic requires a very different approach to patient management: we ne...

COVID-19 & SOCIETY

Francesco Giovinazzo, A. Gemelli University Hospital

6 August 2020 | Performing surgery during a global pandemic requires a very different approach to patient management: we need to learn quickly to prepare hospitals and patients for a second wave, explains Francesco Giovinazzo of the Fondazione Policlinico Universitario A Gemelli IRCCS in Rome, and Specialty Chief Editor of Frontiers in Oncology. »Watch


Coronavirus #COVID19 #SARSCoV2 #immunity #immunology #cytokines The discovery of two distinctive features of our immune response to COVID-19 delivers new op...

COVID-19 IMMUNOLOGY

Adrian Hayday, King’s College London

9 July 2020 | New research on the immune response reveals possible early warning signs for severe COVID-19 symptoms, as discovered by Adrian Hayday and his team at King’s College London. »Watch

COVID-19 & SOCIETY

Elliot Berry, Hebrew University Hadassah Medical School

25 June 2020 | What lessons have we learned about coping in a global pandemic? Elliot Berry of Hebrew University on coping strategies developed during the pandemic - many of which may be here to stay. »Watch

Coronavirus #COVID19 #SARSCoV2 #complement #treatment Levels of C5a, a component of the immune complement system, correlate with COVID-19 severity - and blo...

CORONAVIRUS TREATMENT

Eric Vivier, Aix Marseille University & Innate Pharma

17 June 2020 | Levels of immune complement component C5a correlate with COVID-19 severity – and blocking its actions may provide a new treatment, explains Eric Vivier from Aix Marseille University and Innate Pharma. »Watch


Coronavirus #COVID19 #SARSCoV2 #diagnosis #AI #machinelearning #CoughVid Can COVID-19 be diagnosed by artificial intelligence? Prof David Atienza Alonso and...

COVID-19 DIAGNOSTICS

David Atienza Alonso, EPFL

17 June 2020 | Can COVID-19 be diagnosed by artificial intelligence? Prof David Atienza Alonso of Swiss Federal Institute of Technology Lausanne (EPFL) on leveraging signal processing, pervasive computing and machine learning to develop an app and website to screen for COVID-19. »Watch

Coronavirus #COVID19 #SARSCoV2 #citizenscience Data shared by over 3 million participants in the COVID-19 Symptom Study has highlighted new symptoms includi...

COVID-19 EPIDEMIOLOGY

Claire Steves, King’s College London

2 June 2020 | How data shared by 3 million participants through the COVID-19 Symptom Study has highlighted new symptoms including loss of taste and smell, with Dr Claire J Steves, Senior Clinical Lecturer and Consultant Physician at King's College London. »Watch

Coronavirus #COVID19 #SARSCoV2 #immunity Understanding the lung immune response to SARS-CoV-2 - and specifically, a protective response versus immunopatholo...

CORONAVIRUS IMMUNITY

Donna Farber, Columbia University

2 June 2020 | Understanding the lung immune response to SARS-CoV-2 – and specifically, a protective response versus immunopathology – is essential for understanding COVID-19 pathogenesis and identifying therapies, explains Prof Donna Farber of Columbia University. »Watch


Coronavirus #COVID19 #SARSCoV2 #airpollution New research links COVID-19 mortality to air pollution - specifically, levels of fine particulate matter - expl...

COVID-19 SEVERITY

Francesca Dominici, Harvard T.H. Chan

28 May 2020 | New research links COVID-19 mortality to small increases atmospheric levels of fine particulate matter, explains Professor Francesca Dominici from the Harvard T.H. Chan School of Public Health. »Watch

Coronavirus #COVID19 #SARSCoV2 #mentalhealth #psychiatry The mental health impacts of surviving COVID-19 infection, living and grieving through a pandemic a...

COVID-19 & SOCIETY

Dinesh Bhugra, King’s College London

14 May 2020 | Mental health impacts of surviving COVID-19 and living & grieving through a pandemic with Dinesh Bhugra, former President of the World Psychiatric Association and Emeritus Professor at King’s College London. »Watch

Coronavirus #COVID19 #SARSCoV2 How is the process of mourning playing out during COVID-19? Prof Lydia Giménez-Llort of the Autonomous University of Barcelon...

COVID-19 & SOCIETY

Lydia Giménez-Llort, Uni. Barcelona

8 May 2020 | How is the process of mourning playing out during COVID-19? Lydia Giménez-Llort, Professor of Psychiatry at the Autonomous University of Barcelona outlines the stages of grief seen within individuals and societies. »Watch


Coronavirus #COVID19 #SARSCoV2 #vaccine #immunity #BCG The BCG vaccine for tuberculosis also provides protection against respiratory viruses. Mihai Netea fr...

CORONAVIRUS VACCINE

Mihai Netea, Radboud University

7 May 2020 | The BCG vaccine for tuberculosis also provides protection against respiratory viruses. Mihai Netea from Radboud University Medical Center discusses how BCG may provide a bridge until a COVID-19 vaccine is available. »Watch

Coronavirus #COVID19 #SARSCoV2 #vaccine #immunity The body's adaptive immune system is very powerful - but vaccination against SARS-CoV-2 will give stronger...

CORONAVIRUS IMMUNITY

Andreas Radbruch, DRFZ

5 May 2020 | The body's adaptive immune system is very powerful – but vaccination against SARS-CoV-2 will give more reliable protection, explains Andreas Radbruch, Scientific Director, Deutsches Rheuma-Forschungszentrum Berlin. »Watch

Coronavirus #COVID19 #SARSCoV2 #test #diagnosis #detection How does COVID-19 testing work? Professor Lisa Ng, Senior Principal Investigator at A*STAR's Sing...

COVID-19 DIAGNOSTICS

Lisa Ng, A*STAR Singapore

1 May 2020 | How does COVID-19 testing work? Professor Lisa Ng, Senior Principal Investigator at A*STAR's Singapore Immunology Network, outlines different methods and how they will help shed light on the disease’s epidemiology. »Watch


Coronavirus #COVID19 #SARSCoV2 #cytokines #immunotherapies #drugrepurposing COVID-19 symptoms are similar to the side effects of some cancer immunotherapies...

COVID-19 TREATMENT

Rachel Humphrey, TIO Bioventures

30 April 2020 | Treatments for side effects of some cancer immunotherapies show promise for COVID-19 patients, explains Rachel Humphrey, Head of R&D at TIO Bioventures Discovery Engine. »Watch

Coronavirus #COVID19 #SARSCoV2 #Senescence #aging SARS-CoV-2 may target senescent cells, which become more common in the body as it ages. Prof Michael Lisan...

COVID-19 TREATMENT

Michael Lisanti, University of Salford

28 April 2020 | SARS-CoV-2 may target senescent cells, which become more common with age -Michael Lisanti, Specialty Chief Editor of Frontiers in Oncology - Cancer Metabolism, on potential targets for treatment. »Watch

Coronavirus #COVID19 #SARSCoV2 #ICU #healthcare #PPE How are frontline medical staff dealing with shortages of ICU beds, ventilators and PPE during the COVI...

COVID-19 TREATMENT

Hannah Wunsch, Sunnybrook Centre

21 April 2020 | Medical staff are overloaded and underequipped: Hannah Wunsch, staff physician and senior scientist at Sunnybrook Health Sciences Centre, on coping with frontline shortages and lessons for the next pandemic. »Watch


Eleanor Fish shares exploratory data on treating COVID-19 patients with interferon-alpha, following previous work showing that treatment with interferon-alpha was beneficial in patients with SARS. Eleanor is a Professor in the Department of Immunology at the University of Toronto. Hear more on this potential coronavirus treatment: Watch Eleanor Fish's scientific webinar at https://youtu.be/8HLnmIWB2rE This video is a collaboration between the International Union of Immunological Societies (IUIS) and Frontiers. See more expert commentaries on the coronavirus outbreak: https://coronavirus.frontiersin.org/

COVID-19 TREATMENT

Eleanor Fish, University of Toronto

23 April 2020 | Early data (under review) on promising results following the treatment of COVID-19 patients with interferon-alpha, from Eleanor Fish, Professor at the University of Toronto. »Watch

Coronavirus #COVID19 #SARSCoV2 #sociology #lockdown #selfisolation The impact of lockdown through a sociological lens: as self-isolation measures take their...

COVID-19 & SOCIETY

Hannah Bradby, Uppsala University

21 April 2020 | The impact of lockdown through a sociological lens: Hannah Bradby, Professor at Uppsala University and Field Chief Editor of Frontiers in Sociology on integrating social costs into epidemiological models. »Watch

Coronavirus #COVID19 #SARSCoV2 #climatechange #recession #economy #sustainable How can we integrate sustainable development goals into the post-COVID-19 eco...

COVID-19 & ECONOMY

Sam Fankhauser & Charles Donovan

21 April 2020 | Integrating sustainable development goals into post-COVID-19 economic recovery with Prof Sam Fankhauser, London School of Economics, and Dr Charles Donovan, Imperial College Business School. »Watch


Coronavirus #COVID19 #SARSCoV2 #science Policy responses to the coronavirus pandemic must be based on scientific evidence - and policy makers must invest in...

COVID-19 & POLICY

Giuseppe Ippolito, INMI

21 April 2020 | Giuseppe Ippolito, Scientific Director at the National Institute for Infectious Disease, Italy, on science-based policy responses and the investments needed to prepare against future infectious diseases. »Watch

Coronavirus #COVID19 #SARSCoV2 #FAIRdata #data How can we collectively share data to more effectively fight the next pandemic? Prof Barend Mons, of Leiden U...

COVID-19 RESEARCH

Barend Mons, GO FAIR Initiative

17 April 2020 | How to prepare for the next outbreak through improved data accessibility, with Barend Mons, Professor at Leiden University Medical Center and scientific director of the GO FAIR initiative. »Watch

Coronavirus #COVID19 #SARSCoV2 #brain #fetalbraindevelopment As latest reports suggest that coronavirus could be infecting brain cells, Professor Thomas Har...

CORONAVIRUS HEALTH IMPACTS

Thomas Hartung, Johns Hopkins

14 April 2020 | Discovering the effects of coronavirus on the human brain with Thomas Hartung, Professor at Johns Hopkins University, Bloomberg School of Public Health and Field Chief Editor, Frontiers in Artificial Intelligence. »Watch


Coronavirus #COVID19 #SARSCoV2 #coronaviruscase #coronavirusspread Predicting coronavirus spread using particle physics with Dr Francesco Sannino, Director ...

CORONAVIRUS SPREAD

Francesco Sannino, CP³-Origins

8 April 2020 | Predicting coronavirus spread using particle physics with Francesco Sannino, Director of the Centre for Cosmology & Particle Physics Phenomenology, University of Southern Denmark, and Associate Editor, Frontiers in Physics. »Watch

Coronavirus #COVID19 #SARSCoV2 #therapeutics #antivirals Giovanni Maga on a promising new drug therapy for COVID-19 patients, and how antiviral treatments w...

COVID-19 TREATMENT

Giovanni Maga, CNR Italy

7 April 2020 | When will we find a treatment for COVID-19? The latest on a promising new drug therapy for coronavirus patients with Giovanni Maga, Director of the Institute of Molecular Genetics, National Research Council, Italy. »Watch

Coronavirus #COVID19 #SARSCoV2 #deforestation #agriculture With 50% of animal-borne human viruses attributed to modern agricultural practices, Paolo Vineis ...

CORONAVIRUS SPREAD

Paolo Vineis, Imperial College London

6 April 2020 | Is there a link between global land use change Paolo Vineis, Field Chief Editor of Frontiers in Public Health, explains how changes in land use worldwide are influencing the spread of coronavirus. »Watch


Coronavirus #COVID19 #SARSCoV2 #Blockchain #SupplyChain Olinga Taeed, Director of the Centre for Citizenship, Enterprise and Governance (CCEG), on maintaini...

COVID-19 & SOCIETY

Olinga Taeed, CCEG

2 April 2020 | How can blockchain help prevent goods shortages during the coronavirus pandemic? Olinga Taeed, Field Chief Editor of Frontiers in Blockchain and CCEG Director, on creating trust through technology. »Watch

Coronavirus #COVID19 #SARSCoV2 #vaccine How long will it really take to develop a vaccine for COVID-19, and how is science speeding up the process? Rino Rap...

COVID-19 VACCINE

Rino Rappuoli, GlaxoSmithKline (GSK)

2 April 2020 | How long until a vaccine for COVID-19, and how is science speeding up the process? Rino Rappuoli, Chief Scientist and Head of Research & Development at GlaxoSmithKline, shares his insights. »Watch

COVID-19 & SOCIETY

i3Health Annual Lectures

27 March 2020 | Hear five leading experts debate on citizenship empowerment, health diplomacy, the role of economists in overcoming the coronavirus crisis, and fostering collaborations across borders. »Watch